50 related articles for article (PubMed ID: 31054158)
1. Loss of SMAD4 protein expression in gastrointestinal and extra-gastrointestinal carcinomas.
Ritterhouse LL; Wu EY; Kim WG; Dillon DA; Hirsch MS; Sholl LM; Agoston AT; Setia N; Lauwers GY; Park DY; Srivastava A; Doyle LA
Histopathology; 2019 Oct; 75(4):546-551. PubMed ID: 31054158
[TBL] [Abstract][Full Text] [Related]
2. Morphologic heterogeneity of carcinoma with signet ring cell features at different primary sites.
Dahoud W; Gullo I; Imam R; Tang LH
Pathobiology; 2023 Dec; ():. PubMed ID: 38142679
[TBL] [Abstract][Full Text] [Related]
3. An Update on the Role of Immunohistochemistry in the Evaluation of Pancreatic/Liver/Gastrointestinal Luminal Tract Disorders.
Huang J; Chen G; Li H
Arch Pathol Lab Med; 2023 Dec; 147(12):1374-1382. PubMed ID: 37134268
[TBL] [Abstract][Full Text] [Related]
4. The impact of somatic SMAD4 mutations in colorectal liver metastases.
Xourafas D; Mizuno T; Cloyd JM
Chin Clin Oncol; 2019 Oct; 8(5):52. PubMed ID: 31500428
[TBL] [Abstract][Full Text] [Related]
5. Lessons learned from SMAD4 loss in squamous cell carcinomas.
Hernandez AL; Young CD; Wang JH; Wang XJ
Mol Carcinog; 2019 Sep; 58(9):1648-1655. PubMed ID: 31140647
[TBL] [Abstract][Full Text] [Related]
6.
Lin LH; Chang KW; Cheng HW; Liu CJ
Front Oncol; 2019; 9():1379. PubMed ID: 31867281
[TBL] [Abstract][Full Text] [Related]
7. SMAD4 Y353C promotes the progression of PDAC.
Wang Z; Li Y; Zhan S; Zhang L; Zhang S; Tang Q; Li M; Tan Z; Liu S; Xing X
BMC Cancer; 2019 Nov; 19(1):1037. PubMed ID: 31684910
[TBL] [Abstract][Full Text] [Related]
8. SMARCB1 (INI-1)-Deficient Adenocarcinoma of the Sinonasal Tract: A Potentially Under-Recognized form of Sinonasal Adenocarcinoma with Occasional Yolk Sac Tumor-Like Features.
Shah AA; Jain D; Ababneh E; Agaimy A; Hoschar AP; Griffith CC; Magliocca KR; Wenig BM; Rooper LM; Bishop JA
Head Neck Pathol; 2020 Jun; 14(2):465-472. PubMed ID: 31468350
[TBL] [Abstract][Full Text] [Related]
9. TFE3 rearranged epithelioid hemangioendothelioma of bone: A clinicopathological, immunohistochemical and molecular study of two cases.
Zhang HZ; Dong L; Wang SY; Yang XQ
Ann Diagn Pathol; 2020 Jun; 46():151487. PubMed ID: 32151991
[TBL] [Abstract][Full Text] [Related]
10. Cytomorphology of hepatoblastoma with histological correlation and role of SALL4 immunocytochemistry in its diagnosis, subtyping, and prognostication.
Nakra T; Roy M; Yadav R; Agarwala S; Jassim M; Khanna G; Das P; Jain D; Mathur SR; Iyer VK
Cancer Cytopathol; 2020 Mar; 128(3):190-200. PubMed ID: 31880869
[TBL] [Abstract][Full Text] [Related]
11. Localisation of PGK1 determines metabolic phenotype to balance metastasis and proliferation in patients with SMAD4-negative pancreatic cancer.
Liang C; Shi S; Qin Y; Meng Q; Hua J; Hu Q; Ji S; Zhang B; Xu J; Yu XJ
Gut; 2020 May; 69(5):888-900. PubMed ID: 31611300
[TBL] [Abstract][Full Text] [Related]
12. SMAD4 mutation correlates with poor prognosis in non-small cell lung cancer.
Wang Y; Xue Q; Zheng Q; Jin Y; Shen X; Yang M; Zhou X; Li Y
Lab Invest; 2021 Apr; 101(4):463-476. PubMed ID: 33303972
[TBL] [Abstract][Full Text] [Related]
13. Recent Advances in Pathology of Intrahepatic Cholangiocarcinoma.
Choi JH; Thung SN
Cancers (Basel); 2024 Apr; 16(8):. PubMed ID: 38672619
[TBL] [Abstract][Full Text] [Related]
14. Significance of TP53, CDKN2A, SMAD4 and KRAS in Pancreatic Cancer.
Stefanoudakis D; Frountzas M; Schizas D; Michalopoulos NV; Drakaki A; Toutouzas KG
Curr Issues Mol Biol; 2024 Mar; 46(4):2827-2844. PubMed ID: 38666907
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic gastrointestinal markers in primary lung cancer and pulmonary metastases.
Malmros K; Lindholm A; Vidarsdottir H; Jirström K; Nodin B; Botling J; Mattsson JSM; Micke P; Planck M; Jönsson M; Staaf J; Brunnström H
Virchows Arch; 2023 Jun; ():. PubMed ID: 37349623
[TBL] [Abstract][Full Text] [Related]
16. An 8q24 Gain in Pancreatic Juice Is a Candidate Biomarker for the Detection of Pancreatic Cancer.
Levink IJM; Srebniak MI; De Valk WG; van Veghel-Plandsoen MM; Wagner A; Cahen DL; Fuhler GM; Bruno MJ
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982172
[TBL] [Abstract][Full Text] [Related]
17. Regulation of transforming growth factor-β signaling as a therapeutic approach to treating colorectal cancer.
Maslankova J; Vecurkovska I; Rabajdova M; Katuchova J; Kicka M; Gayova M; Katuch V
World J Gastroenterol; 2022 Sep; 28(33):4744-4761. PubMed ID: 36156927
[TBL] [Abstract][Full Text] [Related]
18. The cytokeratin 17 expression in primary ovarian tumors has diagnostic but not prognostic significance.
Dundr P; Bazalová B; Bártů M; Bosse T; Drozenová J; Fabian P; Fadare O; Hausnerová J; Jakša R; Laco J; Lax SF; Matěj R; McCluggage WG; Méhes G; Michálková R; Němejcová K; Singh N; Stolnicu S; Škapa P; Švajdler M; Stružinská I
Virchows Arch; 2022 Aug; 481(2):201-212. PubMed ID: 35554675
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Roles of ZNF703 and SMAD4 Expression in Patients with Papillary Thyroid Cancer and Association with Nodal Metastasis.
Mohamed AH; Harb OA; Shorbagy SE; Balata R; Amin MF; Abd-Elaziz O
Indian J Surg Oncol; 2022 Mar; 13(1):169-177. PubMed ID: 35462659
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
